Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | LTC4S | Q16873 | 5/20 | 0.44 |
| ▸ | STAT3 | P40763 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.41 |
| ▸ | UTS2R | Q9UKP6 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2743161 | 0.95 | LMNA (0.48) | SRD5A2LMNAL3MBTL1LTC4SMAPT | |
| SCHEMBL2743160 | 0.92 | MRGPRX4 (0.45) | SRD5A2LMNAL3MBTL1AKR1C3PGR | |
| SCHEMBL2743156 | 0.90 | LTC4S (0.49) | LMNAL3MBTL1LTC4SMAPTSMN1; SMN2 | |
| SCHEMBL231253 | 0.90 | LMNA (0.46) | SRD5A2LMNAL3MBTL1PGRLTC4S | |
| SCHEMBL231355 | 0.89 | LTC4S (0.46) | SRD5A2LMNAL3MBTL1AKR1C3LTC4S | |
| SCHEMBL2743159 | 0.89 | LMNA (0.46) | SRD5A2LMNAL3MBTL1LTC4SMAPT | |
| SCHEMBL10176169 | 0.88 | PGR (0.43) | SRD5A2LMNAL3MBTL1AKR1C3PGR | |
| SCHEMBL231264 | 0.88 | L3MBTL1 (0.45) | SRD5A2LMNAL3MBTL1LTC4SMAPT | |
| SCHEMBL2743158 | 0.88 | SRD5A2 (0.47) | SRD5A2LMNAL3MBTL1LTC4SMAPT | |
| SCHEMBL2743157 | 0.88 | LTC4S (0.46) | SRD5A2LMNAL3MBTL1LTC4SSTAT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120004228-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | BIOLIPOX AB (SW) | 2012-01-05 | — | — | US | disclosed |
| US-20120004228-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | BIOLIPOX AB (SW) | 2012-01-05 | — | — | US | disclosed |
| US-20120004228-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | BIOLIPOX AB (SW) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120004228-A1 | Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors | LTC4S, LTB4R2, LTB4R | SRD5A2 564/4885LMNA 1141/4885L3MBTL1 324/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.